SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-21-000060
Filing Date
2021-04-29
Accepted
2021-04-29 16:02:08
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20210331.htm   iXBRL 10-Q 804696
2 EX-10.1 exhibit101stepheneckemploy.htm EX-10.1 132034
3 EX-31.1 exhibit31-1q12021.htm EX-31.1 9168
4 EX-31.2 exhibit31-2q12021.htm EX-31.2 9170
5 EX-32.1 exhibit32-1q12021.htm EX-32.1 4098
6 EX-32.2 exhibit32-2q12021.htm EX-32.2 3933
  Complete submission text file 0001125345-21-000060.txt   4273503

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20210331.xsd EX-101.SCH 30152
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20210331_cal.xml EX-101.CAL 48545
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20210331_def.xml EX-101.DEF 170566
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20210331_lab.xml EX-101.LAB 406021
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20210331_pre.xml EX-101.PRE 279181
12 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20210331_htm.xml XML 598057
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 21870347
SIC: 2834 Pharmaceutical Preparations